抗高血压药物和膝关节骨关节炎之间的因果关系:一种药物向的门德尔随机化研究
Zhixin Li1,2, Yuhao Si1,3, Mengmin Liu1,4
1Institute of Traumatology, New Technology on Trauma Repairment and Reconstruction Laboratory, Nanjing, China.
Medicine
|November 5, 2025
概括
针对SLC12A2基因的抗高血压药物可以降低膝关节关节炎 (KOA) 的风险. 这表明SLC12A2抑制剂可能是高血压和KOA患者的有益治疗选择.
科学领域:
- 药物基因组学 药物基因组学
- 整形外科 整形外科 整形外科
- 心血管医学 心血管医学
背景情况:
- 高血压和膝关节关节炎 (KOA) 经常在患者中并存.
- 了解抗高血压药物治疗和KOA之间的关系对于有效的患者管理至关重要.
研究的目的:
- 使用孟德尔随机化研究抗高血压药物对膝关节骨关节炎 (KOA) 的因果关系.
- 在高血压治疗的背景下,确定KOA的潜在治疗点.
主要方法:
- 使用孟德尔的随机化 (MR) 分析.
- 在药物位基因附近使用单核酸多态 (SNPs) 与缩血压相关的基因作为工具变量.
- 使用全基因组关联研究 (GWAS) 数据分析了影响药物标的遗传变异和KOA风险之间的关联.
主要成果:
- 发现SLC12A2基因表达减少与膝关节关节炎 (KOA) 风险降低之间存在显著的逆相关性.
- 与SLC12A2基因表达相关的KOA风险降低的几率比为0.915 (95%CI:0.869-0.964,P <.001).
结论:
- SLC12A2基因的抑制剂对膝关节骨关节炎 (KOA) 具有潜在的有益作用.
- 该SLC12A2基因代表了一个有前途的治疗标,用于开发新的治疗KOA.
- 临床医生可能会考虑在患有并发性高血压和KOA的患者中优先考虑SLC12A2抑制剂.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K


